Maciej Banach
Johns Hopkins University
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
Lipoproteins and Cardiovascular Health
Strong evidence · 5 supporting papers · latest 2026
Congenital Heart Disease Studies
Strong evidence · 1 supporting paper · latest 2026
Lipid metabolism and disorders
Strong evidence · 1 supporting paper · latest 2026
Smoking Behavior and Cessation
Solid evidence · 1 supporting paper · latest 2026
Pancreatitis Pathology and Treatment
Solid evidence · 1 supporting paper · latest 2026
Diabetes, Cardiovascular Risks, and Lipoproteins
Solid evidence · 4 supporting papers · latest 2026
Diabetes Treatment and Management
Solid evidence · 2 supporting papers · latest 2026
Hemoglobinopathies and Related Disorders
Solid evidence · 2 supporting papers · latest 2026
Publications (16)
Repaired tetralogy of Fallot across adulthood: from right ventricular remodelling to targeted intervention
2026DOIPMID 42734858
The Impact of Estimated Small Dense Low-Density Lipoprotein Cholesterol on All-Cause Mortality Across the Low-Density Lipoprotein Cholesterol Spectrum – Analysis of Longitudinal LIPIDOGRAM Studies of Polish Primary Care Patients
2026DOI
Global Genetic Architecture of Familial Chylomicronaemia Syndrome: Insights from the FCS International Collaboration Project (FCS IP).
2026DOI
GLP-1 receptor agonists and SGLT2 inhibitors in cardiovascular practice: insights from a national survey of French cardiologists.
2026DOI
Global, regional, and national prevalence of second-hand smoke and attributable disease burden in 204 countries and territories, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
2026DOI
OLEZARSEN FOR ACUTE PANCREATITIS RISK IN PATIENTS WITH TRIGLYCERIDES >10 MMOL/L
2026DOI
Real-world patterns in lipid profile testing and lipid-lowering therapy in hospitalized patients: The Jurasz Lipid Study
2026DOIPMID 42751564
GLOBAL RISK OF PANCREATIC COMPLICATIONS IN FAMILIAL CHYLOMICRONAEMIA SYNDROME (FCS) AND MULTIFACTORIAL CHYLOMICRONAEMIA SYNDROME (MCS): INITIAL INSIGHTS FROM THE FCS INTERNATIONAL COLLABORATION PROJECT.
2026DOI
GLOBAL GENETIC LANDSCAPE OF FAMILIAL CHYLOMICRONAEMIA SYNDROME: INSIGHTS FROM THE FCS INTERNATIONAL COLLABORATION PROJECT (FCS IP).
2026DOI
INCLISIRAN-BASED LIPID MANAGEMENT AND PATIENT-REPORTED OUTCOMES: ASSESSING THE IMPACT OF MUSCLE-RELATED ADVERSE EVENTS IN THE VICTORION-DIFFERENCE TRIAL
2026DOI
Beyond muscle: could GLP-1 receptor agonists offset the tendon risk of intensive lipid-lowering therapy?
2026DOI
IMPACT OF EVINACUMAB ON CORONARY PLAQUES IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: PROTOCOL OF THE "EVOLVE-HOFH" STUDY
2026DOI
Healthcare professional awareness and use of inflammation-based risk assessment in ASCVD: The CARDIO-INFLAME survey
2026DOI
Comparative biomarker efficacy of cholesteryl ester transfer protein inhibitors: a network meta-analysis
2026DOIPMID 42663147
Author Correction: Obesity rise plateaus in developed nations and accelerates in developing nations
2026DOI
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- Johns Hopkins University
Source: OpenAlex · retrieved 2026-09-29
Source: ScienceWe Extractor · retrieved 2026-09-27